Lung Cancer Screening Communication in the US, 2022
Menée aux Etats-Unis à partir d'une enquête réalisée auprès d'un échantillon de 1 279 anciens fumeurs ou fumeurs à risque élevé de développer un cancer du poumon, cette étude examine, en fonction de leur statut tabagique ainsi que de leurs caractéristiques cliniques, démographiques et socio-économiques, l'efficacité de la communication réalisée en 2022 sur le dépistage des cancers du poumon
Lung cancer is the leading cause of cancer death in the US.1 Through routine screening with low-dose computed tomography (LDCT), LC mortality can be averted.2 Current guidelines recommend lung cancer screening (LCS) for 50- to 80-year-old high-risk individuals (ie, former or current smoking), approximating 13 million LCS-eligible US individuals.3,4 However, in 2022, only 4.5% of LCS-eligible individuals were up to date according to the American Lung Association (ALA).5 Discussion about LCS with eligible individuals is foundational for LCS uptake. However, LCS communication by health care practitioners with high-risk adults remains unclear.6 The objective of this study was to examine LCS communication for US individuals at high risk by smoking status and demographic, socioeconomic, and clinical characteristics.
JAMA Network Open , article en libre accès, 2023